Showing results (61-70 of 279) with videos related to
Sort By:
Pageof 28
European Heart Journal|February 3, 1998
Can drug effects on mortality in heart failure be predicted by any surrogate measure?K M Yee, A D StruthersCirculation|February 15, 2000
Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failureC A Farquharson, A D StruthersPostgraduate Medical Journal|January 1, 1983
The haemodynamic effects of labetalol under conditions of increased levels of circulating catecholaminesA D Struthers, J L ReidJournal of Cardiovascular Pharmacology|January 1, 1997
The practical assessment of compliance with ACE-inhibitor therapy--a novel approachR J MacFadyen, A D StruthersHeart (British Cardiac Society)|May 17, 2005
Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failureA D Gavin, A D StruthersBritish Journal of Clinical Pharmacology|April 1, 1994
Interactive effects of indomethacin, angiotensin II and frusemide on renal haemodynamics and natriuresis in manJ G Motwani, A D StruthersJournal of Hypertension|November 1, 1991
Angiotensin II augments the stroke volume response to isoprenaline in manP H Seidelin, A D StruthersHypertension (Dallas, Tex. : 1979)|January 1, 1989
Atrial natriuretic factor inhibits isoproterenol- and furosemide-stimulated renin release in humansJ J McMurray, A D StruthersEuropean Journal of Clinical Pharmacology|January 1, 1988
Respiratory function measurements in clinical pharmacological studies including an assessment of the area under the MEFV curve as a new parameter in chronic bronchitic patientsA D Struthers, G J AddisClinical Science (London, England : 1979)|April 1, 1992
Dose-response study of the redistribution of intravascular volume by angiotensin II in manJ G Motwani, A D StruthersPageof 28